MANILA, Philippines – Justice Secretary Vitaliano Aguirre has already assigned the National Bureau of Investigation (NBI) to find out the possible responsibility of former officials in the previous administration with regard to the reported anomaly in the dengue vaccine program.
“Why was it used? Was there any instruction or was the vaccine clarified that it cannot be administered to those who have not contracted dengue?” said Aguirre.
Among those who will be investigated is the manufacturer and supplier of Dengvaxia, the anti-dengue vaccine that was administered to more than 700,000 children in 2016.
The secretary said, the investigation will find out the vaccine’s possible effect on the children who were vaccinated.
He said, he personally received some of the complaints of the parents of the affected children.
“One of my friends messaged me that their 4-year old was vaccinated last April 2016. The child now has ‘baby TB’ and has weakened immune system. Their expenses are huge,” Aguirre said.
The secretary assured that someone will be held accountable for the anomaly in the anti-dengue vaccine.
He said it cannot be denied that some of the former officials of the previous administration had some lapses. But according to the secretary, they will wait first for the result of the investigation on what cases can be filed and who will be accused.
The NBI will also investigate for possible corruption in the P3.5 million Dengvaxia contract. – Roderic Mendoza | UNTV News & Rescue
MANILA, Philippines — The emergency use authorization (EUA) issued last week by the Food and Drug Administration (FDA) to drug-maker Pfizer-BioNTech for its COVID-19 vaccine will not be revoked yet pending an investigation into claims that it caused the death of some elderly people in Norway, the Department of Health (DOH) said Monday.
Health Undersecretary Maria Rosario Vergeire said Norwegian authorities are still looking into reports that 23 individuals aged 75 to 80 with underlying health conditions died after getting inoculated with COVID-19 vaccine developed by Pfizer-BioNTech.
Vergeire also said that studies need to be done on the matter.
“Pfizer has to submit a report to the Philippine Food And Drug Administration regarding this matter. Once we evaluate the report, base sa kanilang conclusion, that’s the time FDA can decide on the EUA of Pfizer. For now,” Vergeire said.
“Hanggang wala pang sufficient evidence that it was caused by vaccines, status quo tayo on this EUA given to Pfizer,” she added.
The FDA granted EUA to Pfizer last January 14, the first out of four applications it received so far. Other applications are AstraZeneca, China’s Sinovac, and Russia’s Gamaleya Institute.
FDA Director-General Eric Domingo said they are still awaiting a report from Norwegian authorities and that they will “revise the conditions of the EUA as needed,” before starting vaccinations as part of the agency’s protocols on the use of vaccines.
Health authorities also reiterated that COVID-19 vaccines will go through stringent evaluation before it can be approved for use in the country.
“Aside from the safety, and the efficacy na meron ang mga bakuna na papasok, titingnan din nila iyon pong social impact nito, titingnan nila ang affordability and titingnan nila sa response ng equity,” Vergeire said.
“They will be evaluating and then they give their recommendation to the Secretary. Kapag positive ang recommendation, we can procure the specific vaccine,” she added. – RRD (with details from Correspondent Aiko Miguel)
MANILA, Philippines – The Department of Health (DOH) on Monday clarified that the prices of novel coronavirus disease (COVID-19) vaccine circulating online were indicative market prices based on the rates published by manufacturers and not the negotiated prices with the Philippine government.
In a statement, the DOH said the prices were generated for the purpose of estimating the proposed budget for the procurement of the vaccine.
The department issued the clarification in response to a price list released by a senator during the Senate’s hearing on the government’s COVID-19 vaccination program.
The price list showed that total prices for two doses of Moderna cost P3,904 – P4,504; Sinovac, P3,629.50; Pfizer, P2,379; Gamaleya, P1,220; COVAX Facility, P854; AstraZeneca, P610; and Novavax, P366.
“These are not, in any way, the negotiated prices that the government and the manufacturer agreed on,” it said.
The DOH then urged the public to “trust and respect the process that the country, through vaccine czar Secretary Carlito Galvez, is undertaking to ensure that Filipinos are afforded the best vaccines at the most ideal prices.”
MANILA, Philippines — The Department of Health (DOH) has recorded 1,895 new confirmed cases of the novel coronavirus disease (COVID-19), bringing the overall number of active cases to 24,691.
As of the health department’s 4:00 PM case bulletin on Sunday (January 17), the DOH reported that 5,868 have recuperated from the disease, effecting 435,991 total number of recoveries; and 11 fatalities, tallying to 9,895 total deaths.
These numbers added up to 500,577 COVID-19 cases nationwide.
Meanwhile, the top 5 cities and provinces with new confirmed COVID-19 cases are Davao (107), Quezon City (106), Isabela (65), Pampanga (63), and Bulacan (62).
A large majority (84.6%) of the reported active cases have exhibited mild symptoms of the disease. Around 6 percent were asymptomatic, while 3 percent manifested severe symptoms. Only less than 1 percent showed moderate symptoms.—/mbmf
UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.